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Tracking resistance genes based on specific structural features of class 1 integrons is an integral 
part of clinical epidemiology. A class 1 integron is a gene capture and expression unit, most 
frequently found in Gram-negative bacteria. They are known to be one of the greatest 
contributors to the spread of multi-drug resistance genes within clinical isolates.  
Recent studies indicate that certain insertion elements target specific regions of class 1 integrons 
creating unique structures. Consequently, the resistance pool in such integrons goes unnoticed in 
standard molecular screening methodologies, although they are equally efficient in expressing 
and disseminating resistance genes. Examples of such class 1 integrons with atypical structures, 
now realised to have widely disseminated within human and animal E. coli populations 
worldwide, were generated by the insertion of a genetic element known as IS26. This project 
aimed to determine the presence of such structures, as well as characterise the diverse complex 
resistance loci (CRL) and virulence cargo of extraintestinal pathogenic E. coli samples in a 
specific Sydney hospital. This was achieved by identifying the virulence-associated and 
antimicrobial resistance gene pool harboured by these strains with a particular focus on insertion 
or deleterious molecular events, discerning the locations of CRL within genome or plasmid 
where possible and observing trends within clonal groups. 
Targeted PCR, Sanger sequencing and next generation short and long read genome sequencing 
techniques in conjunction with bioinformatic analyses were used to characterise clinical E. coli 
samples from Sydney Adventist Hospital isolated between 2009 and 2011.  
Our data suggests that antibiotic resistance is readily transferring between host populations via 
lateral gene transfer of mobile elements in Sydney through the observation of unique molecular 
signatures. Clonal groups were identified in the cohort which share virulence and antimicrobial 
resistance traits, in some cases at seemingly differing stages of evolution. Large scale studies 





Certificate of Authorship ................................................................................................................ 2 
Peer Reviewed Publications ............................................................................................................ 3 
Conference Presentations ................................................................................................................ 4 
Abstract ........................................................................................................................................... 5 
Abbreviations ................................................................................................................................ 12 
Chapter 1: Background ................................................................................................................. 14 
1.1 Antibiotics and the Evolution of Resistance ................................................................... 15 
1.2 Lateral Gene Transfer ...................................................................................................... 18 
1.2.1 The Concept ................................................................................................................ 18 
1.2.2 Homologous Recombination ..................................................................................... 20 
1.2.3 Site-specific Recombination ...................................................................................... 21 
1.3 Established Escherichia coli Lineages ............................................................................. 21 
1.3.1 Lateral Gene Transfer and Drug Resistance in E. coli........................................... 24 
1.4 Mobile Genetic Elements .................................................................................................. 25 
1.4.1 Plasmids ...................................................................................................................... 26 
1.4.2 Transposons and Insertion Elements ....................................................................... 29 
1.4.3 Integrons ..................................................................................................................... 30 
1.4.4 Genomic Islands ......................................................................................................... 33 
1.4.5 Complex Resistance Loci ........................................................................................... 33 
1.5 Class 1 Integrons: Evolution and Zoonosis .................................................................... 37 
1.6 Experimental Rationale and Approach .......................................................................... 40 
1.6.1 List of Methodologies and Software ......................................................................... 41 
Chapter 2: A draft genome of Escherichia coli sequence type 127 strain 2009-46 ..................... 44 
Abstract .................................................................................................................................... 46 
7 
 
Background ......................................................................................................................... 46 
Results .................................................................................................................................. 46 
Conclusion ........................................................................................................................... 46 
Background ............................................................................................................................. 46 
Methods .................................................................................................................................... 47 
Genome sequencing ............................................................................................................ 47 
Assembly and annotation ................................................................................................... 48 
Quality assurance ................................................................................................................ 48 
Initial findings ......................................................................................................................... 48 
Antibiotic resistance profile ................................................................................................... 50 
Future directions ..................................................................................................................... 51 
Availability of supporting data .............................................................................................. 51 
Competing interests ................................................................................................................ 51 
Authors’ contributions ........................................................................................................... 51 
Acknowledgements ................................................................................................................. 51 
References ................................................................................................................................ 55 
Chapter 3:  Multidrug resistant uropathogenic Escherichia coli ST405 with a novel, composite 
IS26 transposon in a unique chromosomal location ..................................................................... 57 
Abstract .................................................................................................................................... 59 
1. Introduction ......................................................................................................................... 60 
2. Materials and Methods ....................................................................................................... 61 
2. 1 Strains, isolation and culture conditions .................................................................... 61 
2.2 DNA purification ........................................................................................................... 61 
2.3 Fosmid library construction, screening and PCR conditions ................................... 62 
2.4 Amplicon and whole genomes sequencing .................................................................. 62 
8 
 
2.5 Bioinformatics ............................................................................................................... 63 
3. Results .................................................................................................................................. 63 
3.1 Genomic analysis of strains 2009-27 and 2009-30 ...................................................... 63 
3.2 Plasmid analysis ............................................................................................................ 64 
3.3 Characterisation of the CRL in strain 2009-27 .......................................................... 65 
3.4 Prevalence of Tn6242 .................................................................................................... 66 
3.5 Comparative phylogenomics of ST405 strains ........................................................... 66 
3.6 Evolution of Tn6242 ...................................................................................................... 67 
3.7 Generation of laterally mobile translocatable units from Tn6242 ........................... 68 
4. Discussion............................................................................................................................. 68 
Acknowledgements ................................................................................................................. 70 
Author contributions .............................................................................................................. 70 
Conflict of Interest .................................................................................................................. 70 
Ethics statement ...................................................................................................................... 70 
References ................................................................................................................................ 75 
Chapter 4: Whole genome analysis of ExPEC ST73 from a single hospital over a 2-year period 
identified different circulating clonal groups ................................................................................ 80 
Abstract .................................................................................................................................... 82 
Data Summary ........................................................................................................................ 82 
Impact Statement .................................................................................................................... 83 
Introduction ............................................................................................................................. 84 
Methods .................................................................................................................................... 85 
Isolate source and culture conditions ................................................................................ 85 
Nucleic acid purification and whole genome sequencing ................................................ 86 
Genome assembly and gene presence ................................................................................ 86 
9 
 
Archived sequence read selection ...................................................................................... 86 
S1-PFGE analysis ................................................................................................................ 87 
SNP based phylogenetic analyses ...................................................................................... 87 
Results ...................................................................................................................................... 88 
Assembly information and statistics.................................................................................. 88 
Public read high-throughput sequencing analysis ........................................................... 88 
Virulence profiles of Sydney strains .................................................................................. 89 
Antibiotic resistance............................................................................................................ 90 
Structure of class 1 integrons in ST73 strains from Sydney ........................................... 91 
Discussion................................................................................................................................. 93 
Author statements ................................................................................................................... 95 
Funding information ............................................................................................................... 95 
Acknowledgements ................................................................................................................. 96 
Ethical statement ..................................................................................................................... 96 
Conflicts of interest ................................................................................................................. 96 
Abbreviations .......................................................................................................................... 96 
References .............................................................................................................................. 103 
Chapter 5: Genomic analysis of multidrug-resistant Escherichia coli ST58 causing urosepsis. 108 
Abstract .................................................................................................................................. 110 
1. Introduction ....................................................................................................................... 111 
Materials and Methods ......................................................................................................... 112 
2.1. Bacterial strains ......................................................................................................... 112 
2.2. Calibrated dichotomous sensitivity (CDS) testing .................................................. 112 
2.3. Whole-genome sequencing and analyses ................................................................. 113 
2.4. Single nucleotide polymorphisms (SNPs) ................................................................ 113 
10 
 
2.5. Nucleotide sequence accession nos. .......................................................................... 114 
3. Results and Discussion ...................................................................................................... 114 
3.1. Whole-genome sequencing and comparative genomic analyses ............................ 114 
3.2. Virulence-associated genes (VAGs) in ST58 strains ............................................... 115 
3.3. Characterisation of the complex resistance locus in the Sydney ST58 strains ..... 115 
3.4. pSDJ2009-52F carries the Tn1721/Tn21 hybrid transposon ................................. 116 
4. Conclusion ......................................................................................................................... 117 
Acknowledgments ................................................................................................................. 118 
Funding .................................................................................................................................. 118 
Competing interests .............................................................................................................. 118 
Ethical approval .................................................................................................................... 118 
References .............................................................................................................................. 123 
Chapter 6: Molecular analysis of an IncF ColV-like plasmid lineage that carries a complex 
resistance locus with a trackable genetic signature..................................................................... 125 
Abstract .................................................................................................................................. 127 
Introduction: ......................................................................................................................... 127 
Methods: ................................................................................................................................ 129 
Sequencing of pSDJ2009-52F........................................................................................... 129 
Single Nucleotide Polymorphism (SNP) Analysis .......................................................... 129 
BEAST2 Analysis .............................................................................................................. 129 
Results: ................................................................................................................................... 130 
Plasmid Information ......................................................................................................... 130 
Virulence and Antibiotic Resistance Gene Carriage ..................................................... 130 
Comparative SNP Analyses ............................................................................................. 131 
BEAST2 Analysis .............................................................................................................. 132 
11 
 
Molecular Signatures ........................................................................................................ 132 
Discussion............................................................................................................................... 133 
CRediT Statement ................................................................................................................. 134 
Funding Statement ................................................................................................................ 135 
References .............................................................................................................................. 141 
Chapter 7: General Discussion.................................................................................................... 144 
7.1 Dominant Lineages in Clinical ExPEC and Trends in Antibiotic Resistance ........... 145 
7.2 IS26-mediated Insertion Signatures and Zoonosis ...................................................... 150 
7.3.1 Limitations ................................................................................................................ 156 






AIEC adherent-invasive E. coli 
APEC avian pathogenic E. coli 
bp base pair  
CDS calibrated dichotomous sensitivity 
CRL complex resistance loci/locus 
CS conserved segment 
DAEC diffusely adhering E. coli 
EAEC enteroaggregative E. coli 
EHEC enterohemorrhagic E. coli 
EIEC enteroinvasive E. coli 
EPEC enteropathogenic E. coli 
ESBL extended spectrum β-lactamase 
ETEC enterotoxigenic E. coli 
ExPEC extra-intestinal pathogenic E. coli 
GI genomic island 
GIT gastro-intestinal tract 
HC hemorrhagic colitis 
HUS haemolytic uraemic syndrome 
Inc incompatibility 
IPEC intestinal pathogenic E. coli 
IS insertion sequence 
kb kilobase  
LB Luria-Bertani/lysogeny broth 
LGT lateral gene transfer 
MDR multi-drug resistant 
MGE mobile genetic element 
MLST multi-locus sequence typing 
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NMEC neonatal meningitis E. coli 
nt nucleotide 
PCR polymerase chain reaction 
PFGE pulsed field gel electrophoresis 
SMAC sorbitol-MacConkey agar 
SMRT single molecule real time 
SNP single nucleotide polymorphism 
SRA sequence read archive 
ST sequence type 
TU translocatable unit 
UPEC uropathogenic E. coli 
UTI urinary tract infection 
VAG virulence-associated gene 
